The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice
Open accessAbstract
Background & aims Effective therapeutics for treating acute colitis, caused by disruption of the intestinal epithelial barrier, are scarce. Trefoil factors (TFF) are cytoprotective and promote epithelial wound healing and reconstitution of the gastrointestinal tract, which makes them good candidate therapeutics for acute colitis. However, orally administered TFF stick to the mucus of the small intestine and are absorbed at the cecum.Methods We have engineered the food-grade bacterium Lactococcus lactis to secrete bioactive murine TFF. The protective and therapeutic potentials of these TFF-secreting L. lactis were evaluated in parallel with purified TFF in the dextran sodium sulfate (DSS)-induced murine model for acute colitis and in established chronic colitis in interleukin (IL)-10(-/-) mice. Disease was evaluated by blinded macroscopic and microscopic inflammatory scores and by myeloperoxidase activity.Results Intragastric administration of TFF-secreting L. lactis led to active delivery of TFF at the mucosa of the colon and, in contrast to administration of purified TFF, proved to be very effective in prevention and healing of acute DSS-induced colitis. The in situ secreted murine TFF significantly decreased morbidity and mortality and stimulated prostaglandin-endoperoxide synthase 2 expression, which represents a major therapeutic pathway. In addition, this approach was successful in improving established chronic colitis in IL-10(-/-) mice.Conclusions We have positively evaluated a new therapeutic approach for acute and chronic colitis that involves in situ secretion of murine TFF by orally administered L. lactis. This novel approach may lead to effective management of acute and chronic colitis and epithelial damage in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Instead of traditional orogastric administration of TFF, which sticks to the mucus layer in the small bowel preventing its localization in the colon, use of the recombinant bacterium enables delivery of TFF directly to the colonic mucosa and results in amelioration of DSS-induced disease in mice.123”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [123]
In the citing paper
“Instead of traditional orogastric administration of TFF, which sticks to the mucus layer in the small bowel preventing its localization in the colon, use of the recombinant bacterium enables delivery of TFF directly to the colonic mucosa and results in amelioration of DSS-induced disease in mice.123”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [123]
In the citing paper
“Instead of traditional orogastric administration of TFF, which sticks to the mucus layer in the small bowel preventing its localization in the colon, use of the recombinant bacterium enables delivery of TFF directly to the colonic mucosa and results in amelioration of DSS-induced disease in mice.123”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,628
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & NAKAYA, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,408
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature reviews. Immunology · doi:10.1038/nri1132 · Cited by 1,796
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Self-citationSingle-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides
Stemmer, W. P. C., Crameri, A., Ha, K. D., Brennan, T. M., & Heyneker, H. L. (1995) · Gene · doi:10.1016/0378-1119(95)00511-4 · Cited by 732
Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor
Mashimo, H. L., Wu, D., Podolsky, D. K., & Fishman, M. C. (1996) · Science · doi:10.1126/science.274.5285.262 · Cited by 702
Trefoil factors: initiators of mucosal healing
Taupin, D. R., & Podolsky, D. K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1203 · Cited by 643
Research works printed but not linked: 2
- Rosenberg, 1997, Epithelial cell kinase-B61, Am J Physiol, 273, G824
- Ehrlich, 1998, Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection, Am J Physiol, 274, G955
Cited by
Sorted by citations
Items 101–200 of 276
Human microbiome restoration and safety
Daliri, E. B., Tango, C. N., Lee, B. H., & Oh, D. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.05.002 · Cited by 50
Polyak, S., Mach, A. S., Porvasnik, S., Dixon, L. R., Conlon, T. J., Erger, K. E., Acosta, A. J., Wright, A. J., Campbell‐Thompson, M., Zolotukhin, I., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00562.2010 · Cited by 48
Karrasch, T., Steinbrecher, K. A., Allard, B., Baldwin, A. S., & Jobin, C. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20626 · Cited by 47
Clavel, T., & Haller, D. (2007) · PubMed · Cited by 46
Effects of probiotics on the gastrointestinal tract
Snelling, A. M. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000182103.32504.e3 · Cited by 46
Effendi, S. S. W., & Ng, I. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2109405 · Cited by 46
Chang, H. M., Loh, T. C., Foo, H. L., & Lim, E. T. C. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.883324 · Cited by 50
Lactic Acid Bacteria for Delivery of Endogenous or Engineered Therapeutic Molecules
Bron, P. A., & Kleerebezem, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01821 · Cited by 43
Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?
Gibson, P. R. (2005) · Gut · doi:10.1136/gut.2004.058453 · Cited by 41
Robert, S., & Steidler, L. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-s1-s11 · Cited by 43
Self-citationBerlec, A., Perše, M., Ravnikar, M., Lunder, M., Erman, A., Cerar, A., & Štrukelj, B. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.12.027 · Cited by 40
Actobiotics™ as a Novel Method for Cytokine Delivery
Steidler, L., Rottiers, P., & Coulie, B. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05067.x · Cited by 40
Self-citationGe, H., Gardner, J., Wu, X., Rulifson, I. C., Wang, J., Xiong, Y., Ye, J., Belouski, E., Cao, P., Tang, J. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126924 · Cited by 39
Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
Marteau, P. R. (2006) · Gut · doi:10.1136/gut.2004.051458 · Cited by 38
Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications
Jahan, R., Shah, A., Kisling, S. G., Macha, M. A., Thayer, S. P., Batra, S. K., & Kaur, S. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188362 · Cited by 39
del Río, B., Redruello, B., Fernández, M., Martín, M. C., Ladero, V., & Álvarez, M. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03179 · Cited by 37
Engineering Tools for the Development of Recombinant Lactic Acid Bacteria
Cho, S. W., Yim, J., & Seo, S. W. (2020) · Biotechnology Journal · doi:10.1002/biot.201900344 · Cited by 37
Quigley, E. M. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-289-6_23 · Cited by 36
Heuer, J., Heuer, F., Stürmer, R., Harder, S., Schlüter, H., Emídio, N. B., Muttenthaler, M., Jechorek, D., Meyer, F. P., & Hoffmann, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072508 · Cited by 35
Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide
Liu, C., Chang, J.-H., Chang, Y.-C., & Mou, Y. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01987-8 · Cited by 35
Ballester, I., Daddaoua, A., López-Posadas, R., Nieto, A., Suárez, M. D., Zarzuelo, A., Martínez‐Augustin, O., & de Medina, F. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707227 · Cited by 34
Stürmer, R., Harder, S., Schlüter, H., & Hoffmann, W. (2018) · ChemBioChem · doi:10.1002/cbic.201800622 · Cited by 33
Liu, S. Q., Roberts, D., Zhang, B., Ren, Y., Zhang, L., & Wu, Y. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077732 · Cited by 33
Probiotics and barrier function in colitis
Gionchetti, P., Lammers, K. M., Rizzello, F., & Campieri, M. (2005) · Gut · doi:10.1136/gut.2004.060640 · Cited by 34
Böhm, S. K., & Kruis, W. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.005 · Cited by 33
Expanding the recombinant protein quality in Lactococcus lactis
Cano‐Garrido, O., Rueda, F. L., Sánchez‐García, L., Ruíz-Ávila, L., Bosser, R., Villaverde, A., & García‐Fruitós, E. (2014) · Microbial Cell Factories · doi:10.1186/s12934-014-0167-3 · Cited by 31
Living Therapeutics: The Next Frontier of Precision Medicine
Kelly, V. W., Liang, B. K., & Sirk, S. J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00444 · Cited by 30
Kouznetsova, I., Kalinski, T., Peitz, U., Mönkemüller, K. E., Kalbacher, H., Vieth, M. W., Meyer, F. P., Roessner, A., Malfertheiner, P., Lippert, H., et al. (2007) · Cell and Tissue Research · doi:10.1007/s00441-006-0350-x · Cited by 31
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier
Stolfi, C., Pacifico, T., Monteleone, G., & Laudisi, F. (2023) · Biomedicines · doi:10.3390/biomedicines11072015 · Cited by 34
Genetically engineered bacteria as inflammatory bowel disease therapeutics
Zou, Z., Zhang, X.-P., Zhang, Q., Yin, B., Zhou, Y. Q., & Ye, B. (2024) · Engineering Microbiology · doi:10.1016/j.engmic.2024.100167 · Cited by 32
Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000
Bahey-El-Din, M., Griffin, B. T., & Gahan, C. G. M. (2008) · Microbial Cell Factories · doi:10.1186/1475-2859-7-24 · Cited by 30
Molecular Alterations in the Stomach of Tff1-Deficient Mice: Early Steps in Antral Carcinogenesis
Znalesniak, E. B., Salm, F., & Hoffmann, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020644 · Cited by 30
Werner, T., Shkoda, A., & Haller, D. (2007) · Journal of Proteome Research · doi:10.1021/pr070222x · Cited by 30
Calcagno, S. R., Li, S., Shahid, M. W., Wallace, M. B., Leitges, M., Fields, A. P., & Murray, N. R. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21547 · Cited by 29
Gelli, H. P., Vazquez-Uribe, R., Buckley, S. T., Andersen, J. T., & Sommer, M. O. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115603 · Cited by 30
Modulation of Gut-Associated Lymphoid Tissue Functions with Genetically ModifiedLactococcus lactis
Rottiers, P., Smedt, T. D., & Steidler, L. (2009) · International Reviews of Immunology · doi:10.3109/08830180903197498 · Cited by 28
Self-citationAdvancement of Engineered Bacteria for Orally Delivered Therapeutics
Guo, P., Wang, S., Yue, H., Zhang, X., Ma, G., Li, X., & Wei, W. (2023) · Small · doi:10.1002/smll.202302702 · Cited by 27
Immunomodulation by genetically engineered lactic acid bacteria
Huynegem, K. V. (2009) · Frontiers in bioscience · doi:10.2741/3571 · Cited by 27
Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier: In Vitro Binding Studies
Heuer, F., Stürmer, R., Heuer, J., Kalinski, T., Lemke, A., Meyer, F. P., & Hoffmann, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235871 · Cited by 27
Huyghebaert, N., Vermeire, A., Rottiers, P., Remaut, E., & Remon, J. P. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.002 · Cited by 27
Self-citationToward Practical Applications of Engineered Living Materials with Advanced Fabrication Techniques
Lu, C., Huang, Y., Cui, J., Wu, J., Jiang, C., Gu, X., Cao, Y., & Yin, S. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00259 · Cited by 27
Fu, T., Znalesniak, E. B., Kalinski, T., Möhle, L., Biswas, A., Salm, F., Dunay, I. R., & Hoffmann, W. (2015) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2015.00028 · Cited by 26
Novel strategies to attenuate immune activation in Crohn's disease
BAMIAS, G., & COMINELLI, F. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.008 · Cited by 26
Lin, J., Peng, L., Itzkowitz, S. H., Holzman, I. R., & Babyatsky, M. W. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000179659.09210.ff · Cited by 26
Wolk, O., Epstein, S., Ioffe, V., Ben‐Shabat, S., & Dahan, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.800480 · Cited by 25
Bioecological control of inflammatory bowel disease
Bengmark, S. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.10.001 · Cited by 25
Mucin utilisation and host interactions of the novel intestinal microbe Akkermansia muciniphila
Derrien, M. (2007) · doi:10.18174/2279 · Cited by 25
Genetically ModifiedLactococcus lactisfor Delivery of Human Interleukin-10 to Dendritic Cells
Huibregtse, I. L., Zaat, S. A., Kapsenberg, M. L., da Silva, M. A. S., Peppelenbosch, M. P., van Deventer, S. J. H., & Braat, H. (2011) · Gastroenterology Research and Practice · doi:10.1155/2012/639291 · Cited by 24
Bennink, R. J., Hamann, J., de Bruin, K. M., ten Kate, F. J. W., van Deventer, S. J. H., & Velde, A. A. T. (2005) · PubMed · Cited by 24
Action and immunomodulatory mechanisms, formulations, and safety concerns of probiotics
Ashaolu, T. J., Greff, B., & Varga, L. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2024-006 · Cited by 26
The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease
Deuring, J. J., de Haar, C. G., Kuipers, E. J., Peppelenbosch, M. P., & van der Woude, C. J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.12.020 · Cited by 23
Ye, J., Erland, L. A. E., Gill, S. K., Bishop, S. L., Verdugo‐Meza, A., Murch, S. J., & Gibson, D. L. (2021) · Biomolecules · doi:10.3390/biom11050738 · Cited by 22
Škrlec, K., Zadravec, P., Hlavničková, M., Kuchař, M., Vaňková, L., Petroková, H., Křížová, L., Černý, J., Berlec, A., & Malý, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071933 · Cited by 22
miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner
Shi, Y., Huang, X., Chen, G.-B., Wang, Y., Liu, Y.-S., Xu, W., Tang, S.-H., Guleng, B., Liu, J.-J., & Ren, J.-L. (2019) · BMC Cancer · doi:10.1186/s12885-018-5247-z · Cited by 22
Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents
Urbanska, A. M., Zhang, X., & Prakash, S. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0528-5 · Cited by 22
Di, W., Zhang, Y., Zhang, X., Han, L., Zhao, L., Hao, Y., & Zhai, Z. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04012-z · Cited by 21
Therapeutic Opportunities in the Vaginal Microbiome
Reid, G. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0001-2016 · Cited by 21
Ruan, H., Huang, Y., Yue, B., Zhang, Y., Lv, J., Miao, K., Zhang, D., Luo, J., & Yang, M. (2023) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13242 · Cited by 23
Nikolaidis, N. M., Wang, T. C., Hogan, S. P., & Rothenberg, M. E. (2006) · Experimental Lung Research · doi:10.1080/01902140601059547 · Cited by 21
Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease
Mitsuyama, K., & Sata, M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.3.301 · Cited by 22
Transgenic probiotica as drug delivery systems: the golden bullet?
Yuvaraj, S., Peppelenbosch, M. P., & Bos, N. A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.1.1 · Cited by 21
Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
Zahirović, A., & Berlec, A. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01873-7 · Cited by 20
Rôles physiologiques des mucines dans la barrière colique
Gaudier, E. A., & Hoebler, C. (2006) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(06)73358-9 · Cited by 20
Huynh, E., & Li, J. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6542-0 · Cited by 20
Hoffmann, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212221 · Cited by 19
Probiotics Upregulate Trefoil Factors and Downregulate Pepsinogen in the Mouse Stomach
Khoder, G., Al-Yassir, F., Menhali, A. A., Saseedharan, P., Sugathan, S., Tomasetto, C., & Karam, S. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163901 · Cited by 19
Plavec, T. V., Mitrović, A., Nanut, M. P., Štrukelj, B., Kos, J., & Berlec, A. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13907 · Cited by 19
Shimada, T., Fujii, Y., Koike, T., Tabei, K., Namatame, T., Yamagata, M., Tajima, A., Yoneda, M., Terano, A., & Hiraishi, H. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.015 · Cited by 19
Mucosa-associated bacteria and metabolites in inflammatory bowel disease: from inside to insight
Wang, X., He, L., Dong, Y., Qin, X., Zhang, H., Wang, B., Wang, S., & Cao, H. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00887-4 · Cited by 21
The Future of Probiotics for Disorders of the Brain-Gut Axis
Quigley, E. M. M., & Shanahan, F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_19 · Cited by 18
E. coli-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study
Yuvaraj, S., Al-Lahham, S., Somasundaram, R., Figaroa, P. A., Peppelenbosch, M. P., & Bos, N. A. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/895462 · Cited by 18
Engineering the next generation of theranostic biomaterials with synthetic biology
Wang, X., Liang, Q., Luo, Y., Ye, J., Yu, Y., & Chen, F. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.018 · Cited by 17
Shi, Y., Chen, G.-B., Huang, Q., Xu, C., Liu, J., Xu, W. F., Huang, X., Liu, Y., Xiao, C., Wu, D., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.016 · Cited by 16
Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease
Minakshi, P., Kumar, R., Ghosh, M., Brar, B., Barnela, M., & Lakhani, P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200320113322 · Cited by 17
Living Drugs for Gastrointestinal Diseases: The Case for Probiotics
Marteau, P. R. (2006) · Digestive Diseases · doi:10.1159/000090317 · Cited by 18
Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite
Emídio, N. B., Meli, R., Tran, H. N. T., Baik, H., Morisset‐Lopez, S., Elliott, A. G., Blaskovich, M. A. T., Spiller, S., Beck‐Sickinger, A. G., Schroeder, C. I., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00767 · Cited by 16
Pang, Q., Ji, Y. H., Bermúdez‐Humarán, L. G., Zhou, Q.-M., Hu, G., & Zeng, Y. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.03.042 · Cited by 16
Probiotics and prebiotics in periodontal therapy
Sandeep, N., Koduganti, R. R., Guduguntla, S., & Gorthi, V. C. (2011) · Indian Journal of Dental Research · doi:10.4103/0970-9290.84312 · Cited by 16
RetractedPath to bacteriotherapy: From bacterial engineering to therapeutic perspectives
Liu, J., He, C., Tan, W., & Zheng, J. H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122897 · Cited by 14
Huang, Y., Peng, S., Zeng, R., Yao, H., Feng, G., & Fang, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127928 · Cited by 19
Fu, T., Kalbacher, H., & Hoffmann, W. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354501 · Cited by 15
Therapeutic implications of the gastrointestinal microbiome
Kashyap, P., & Quigley, E. M. M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.01.004 · Cited by 15
Production of Membrane Proteins in Escherichia coli and Lactococcus lactis
Geertsma, E. R., & Poolman, B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-344-2_2 · Cited by 14
Engineering Diagnostic and Therapeutic Gut Bacteria
Landry, B. P., & Tabor, J. J. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch14 · Cited by 12
Emídio, N. B., Baik, H., Lee, D., Stürmer, R., Heuer, J., Elliott, A. G., Blaskovich, M. A. T., Haupenthal, K., Tegtmeyer, N., Hoffmann, W., et al. (2020) · Chemical Communications · doi:10.1039/d0cc02321c · Cited by 13
Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease
Boix-Amorós, A., Monaco, H., Sambataro, E., & Clemente, J. C. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2107866 · Cited by 13
Mobilization of Bone Marrow Cells by Leukocytapheresis in Patients With Ulcerative Colitis
Mitsuyama, K., Andoh, A., Masuda, J., Yamasaki, H., Kuwaki, K., Takedatsu, H., Seki, R., Nishida, H., Tsuruta, O., & Sata, M. (2008) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2008.00587.x · Cited by 13
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
Marteau, P. R., Sokol, H., Dray, X., & Seksik, P. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(09)73158-6 · Cited by 13
Xue, Y., Hu, M., Cha, S., Xue, C., & Dong, N. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.10.012 · Cited by 13
Zhao, L., Xin, J., Hu, M., Xue, C., & Dong, N. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.028 · Cited by 15
Pang, Q., Ji, Y. H., Li, Y., Bermúdez‐Humarán, L. G., Hu, G., & Zeng, Y. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01141.x · Cited by 12
Afchangi, A., Latifi, T., Jalilvand, S., Marashi, S. M., & Shoja, Z. (2021) · Archives of Virology · doi:10.1007/s00705-021-04964-9 · Cited by 11
Denholm, J. T., Horne, K., McMahon, J. H., Grayson, M. L., & Johnson, P. D. R. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500504158 · Cited by 11
RECOMBINANT TECHNOLOGY AND PROBIOTICS
D’Silva, I. (2011) · Cited by 11
TFF (Trefoil Factor Family) Peptides
Hoffmann, W. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50160-4 · Cited by 11
Modulation of Stem Cell Progeny by Probiotics during Regeneration of Gastric Mucosal Erosions
Al-Yassir, F., Khoder, G., Sugathan, S., Saseedharan, P., Menhali, A. A., & Karam, S. M. (2021) · Biology · doi:10.3390/biology10070596 · Cited by 11
Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein
Rodríguez‐Díaz, J., Montava, R., Viana, R., Buesa, J., Pérez‐Martínez, G., & Monedero, V. (2011) · Biotechnology Letters · doi:10.1007/s10529-011-0551-6 · Cited by 10
Barrett, K. E. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00340.2005 · Cited by 10
Microbiome engineering: unlocking therapeutic potential in inflammatory bowel disease
Chen, K., Huang, L.-B., Yang, M., Yue, N.-N., Luo, D., Zhang, Y., Tian, C., Song, Y., Wei, D., Shi, R., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1610029 · Cited by 11
Laskou, A., Znalesniak, E. B., Harder, S., Schlüter, H., Jechorek, D., Langer, K., Strecker, C., Matthes, C., Tchaikovski, S. N., & Hoffmann, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042287 · Cited by 9
Metadata
- Authors
- Vandenbroucke, K., Hans, W., Van Huysse, J., Neirynck, S., Demetter, P., Remaut, E., Rottiers, P., & Steidler, L.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University College Cork (IE)
- Ghent University Hospital (BE)
- Corresponding author
- Steidler, Lothar
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 127
- Issue
- 2
- Pages
- 502-513
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2116185627
- Cited by
- 277
- References
- 50
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 12 · 2021: 13 · 2020: 17 · 2019: 9 · 2018: 14 · 2017: 7 · 2016: 4 · 2015: 13 · 2014: 9 · 2013: 13 · 2012: 8
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- trefoil factor, Lactococcus lactis, acute colitis, chronic colitis, IL-10 knockout mice, DSS-induced colitis, epithelial repair, intestinal epithelial barrier, cyclooxygenase-2, mucosal protection, engineered bacteria
- MeSH terms
- Trefoil Factor-2, Trefoil Factor-3, Acute Disease, Administration, Oral, Animals, Chronic Disease, Colitis, Female, Isoenzymes, Mice, Inbred BALB C, Mucins, Muscle Proteins, Neuropeptides, Peptides, Prostaglandin-Endoperoxide Synthases, Recombinant Proteins, Lactococcus lactis, Wound Healing, Genetic Therapy, Gene Expression Regulation, Enzymologic, Mice, Cyclooxygenase 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
